Short-and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic …

G Ashrith, VV Lee, MAA Elayda, RM Reul… - The American journal of …, 2010 - Elsevier
Coronary artery disease (CAD) is the leading cause of morbidity and mortality in patients
with chronic kidney disease (CKD), but no study has yet compared the short-and long-term …

Comparison of drug-eluting stents and coronary artery bypass grafting for the treatment of multivessel coronary artery disease in patients with chronic kidney disease

ZJ Wang, YJ Zhou, YY Liu, DM Shi, YX Zhao… - Circulation …, 2009 - jstage.jst.go.jp
Background: Chronic kidney disease (CKD) is a strong predictor of mortality after
percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), but the …

Revascularization in patients with multivessel coronary artery disease and chronic kidney disease: everolimus-eluting stents versus coronary artery bypass graft …

S Bangalore, Y Guo, Z Samadashvili, S Blecker… - Journal of the American …, 2015 - jacc.org
Background: Randomized trials of percutaneous coronary intervention (PCI) versus
coronary artery bypass graft (CABG) routinely exclude patients with chronic kidney disease …

Comparative efficacy of coronary revascularization procedures for multivessel coronary artery disease in patients with chronic kidney disease

JK Roberts, SV Rao, LK Shaw, DS Gallup… - The American journal of …, 2017 - Elsevier
Patients with chronic kidney disease (CKD) are at increased risk of cardiovascular disease
and death, yet little data exist regarding the comparative efficacy of coronary …

Comparison of coronary artery bypass grafting and drug-eluting stents in patients with chronic kidney disease and multivessel disease: a meta-analysis

Y Wang, S Zhu, P Gao, Q Zhang - European journal of internal medicine, 2017 - Elsevier
Background The optimal revascularization strategy of coronary artery bypass grafting
(CABG) versus percutaneous coronary intervention with drug-eluting stent (PCI-DES) in …

Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS)

JH Ix, N Mercado, MG Shlipak, PA Lemos… - American heart …, 2005 - Elsevier
BACKGROUND: Chronic kidney disease (CKD) is associated with adverse outcomes after
coronary artery bypass graft surgery (CABG) and percutaneous coronary interventions (PCI) …

Comparative effectiveness of coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary disease in a community-based …

TI Chang, TK Leong, DS Kazi, HS Lee, MA Hlatky… - American heart …, 2013 - Elsevier
BACKGROUND: Randomized clinical trials comparing coronary artery bypass grafting
(CABG) with percutaneous coronary intervention (PCI) have largely excluded patients with …

Clinical outcomes of treatment by percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with chronic kidney disease undergoing …

W Chan, J Ivanov, D Ko, S Fremes, V Rao… - Circulation …, 2015 - Am Heart Assoc
Background—There is a paucity of data on the comparative effectiveness of percutaneous
coronary intervention using contemporary drug-eluting stent (DES) compared with coronary …

Multivessel coronary revascularization strategies in patients with chronic kidney disease: a meta-analysis

P Wu, F Luo, Z Fang - Cardiorenal Medicine, 2019 - karger.com
Background: Early revascularization can lead to better prognosis in multivessel coronary
artery disease (CAD) patients with chronic kidney disease (CKD). However, whether …

Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation

LA Szczech, PJ Best, E Crowley, MM Brooks… - Circulation, 2002 - Am Heart Assoc
Background—Although severe chronic kidney disease (CKD) is an independent predictor of
mortality among patients with coronary artery disease, the impact of mild CKD on morbidity …